Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions.
This research is looking at a new 50mg prolonged-release mirabegron tablet. Mirabegron is a medicine often used for bladder problems. This study, called a bioequivalence study, wants to check if this new tablet acts in the body in the same way as the original, established tablet. This comparison is really important for healthy adults who are fasting (haven't eaten). Studies like this help to ensure that when a new version of an existing medicine is made, it will be just as safe and effective for people who need it. Participants in this study won't have any specific medical conditions.
At a glance
What is this study about?
This study is called a 'bioequivalence' study. That's a medical term, but in simple terms, it means researchers are comparing two versions of the same medicine. They want to see if a new 50mg mirabegron tablet works in the body in exactly the same way as an existing, approved 50mg mirabegron tablet. Think of it like comparing two different brands of the same common painkiller; you'd want to know they both do the same job.
Mirabegron is a medicine that's often used to help people with bladder problems. The 'prolonged-release' part means the medicine is designed to release slowly into your body over time, so you don't have to take it as often. This study is being done on healthy people, not people with bladder issues. This helps researchers focus purely on how the medicine behaves in the body without other health problems affecting the results.
Why is this important? It's all about making sure medicines are reliable. If a new version of a medicine is introduced, doctors and patients need to be confident that it will have the same effect as the original. By doing this comparison, researchers help guarantee that future patients will receive a consistent and effective treatment.
Key takeaways
- This study compares a new mirabegron tablet to an original one.
- It's for healthy adult volunteers (aged 18+).
- The goal is to ensure the new tablet works just as safely and effectively.
- Participation involves clinic visits, fasting, and blood tests.
- You will contribute to understanding how new medicines work.
- You can withdraw from the study at any time.
Who may be eligible?
This study is looking for healthy adult volunteers. 'Healthy' means you shouldn't have any serious ongoing medical problems or conditions that might affect how your body handles medicines.
You need to be at least 18 years old to take part. There isn't an upper age limit mentioned, so older adults who are generally healthy can also be considered.
Both men and women are welcome to participate in this study. The researchers want to get a good understanding of how the medicine works in a broad group of people.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I at least 18 years old?
- Am I considered generally healthy with no serious ongoing medical conditions?
- Am I able to fast (not eat or drink, except water) for specific periods?
- Am I available for multiple clinic visits, including potential overnight stays?
- Am I comfortable with having blood tests done?
What does participation involve?
If you take part in this study, you'll be given the study medication. You'll likely have several visits to a clinic over a period, which might include an overnight stay, especially during the times you're taking the medicine. During these visits, there will be various assessments to see how the medicine is working in your body. This will include blood tests to measure the levels of the medicine over time, and possibly other basic health checks like blood pressure and heart rate.
You will be asked to fast (not eat or drink, except water) for a certain period before and after taking the study medication. This is to ensure consistent results. The total duration of your involvement could range from a few weeks, including screening, dosing periods, and follow-up, but specific details would be given by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What is 'bioequivalence'?
It means researchers are checking if a new version of a medicine works in your body in exactly the same way as an existing one.
Do I need to have a bladder problem to join?
No, this study is for healthy people, not those with specific medical conditions. They want to see how the medicine works in a healthy body.
Will I have to stay overnight at a clinic?
Yes, it's likely you will need to stay overnight during the periods when you take the study medicine so they can monitor you closely.
Will I be paid for taking part?
Often, studies like this offer some payment to cover your time and travel, but you should confirm this with the study team.
Can I stop being in the study if I change my mind?
Yes, you are free to leave the study at any time, for any reason, without it affecting your future medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.